Handmade quality · Free shipping over $75 · Explore the atelier

Trilaciclib 60012 Early controlled release of peroxisome

SKU: 26421672111

4.3
USD144.00 USD188.00

Pay in 4 interest-free payments of $36.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 26 - Jul 31

Description

Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment

[Epub ahead of print] PubMed PMID: 29233660

2019 Mar 29

Molecular Weight: 633

Trilaciclib 60012 Early controlled release of peroxisomeTrilaciclib (G1T28, G1T28 1) is a highly potent, selective and reversible cyclin dependent kinase 4 and 6 (CDK4 6) inhibitor. Trilaciclib inhibits CDK4 cyclin D1 and CDK6 cyclin D3 with IC50 of 1 nM and 4 nM, respectively. Product information CAS Number: 1374743 00 6 Molecular Weight: 446. 55 Formula: C24H30N8O Chemical Name: 2' ((5 (4 methylpiperazin 1 yl)pyridin 2 yl)amino) 7',8' dihydro 6'H spiro[cyclohexane 1,9' pyrazino[1',2': 1,5]pyrrolo[2,3

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products